The use of botanically derived agents for hyperpigmentation

A systematic review

Whitney A. Fisk, Oma Agbai, Hadar A. Lev-Tov, Raja K Sivamani

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background Hyperpigmentation disorders are common among those seeking care from dermatologists and primary care physicians. The cosmeceutical and natural product industries are rapidly growing and many botanical agents are purported to improve hyperpigmentation disorders. Objective We sought to review clinical evidence for the use of botanical agents in the treatment of hyperpigmentation. Methods We searched MEDLINE and Embase databases and a total of 26 articles met inclusion criteria. Study methodology was analyzed and the reproducibility of the studies was graded. Results Several botanical agents appear promising as treatment options but few studies were methodologically rigorous. Several plant extract and phytochemicals effectively lighten signs of epidermal melasma and hyperpigmentation induced by ultraviolet radiation exposure. Results were mixed for treatment of solar lentigines or dermal hyperpigmentation. Limitations There were few rigorously designed studies; future research will be critical to further ascertain the discussed results. Conclusions The subtype of hyperpigmentation is important for treatment prognosis, with dermal hyperpigmentation less responsive to treatment. Botanical extracts may play an integrative role in the treatment of hyperpigmentation and further studies that integrate them with standard therapies are needed. Side effects, including worsened hyperpigmentation, need to be discussed when considering these therapies.

Original languageEnglish (US)
Pages (from-to)352-365
Number of pages14
JournalJournal of the American Academy of Dermatology
Volume70
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint

Hyperpigmentation
Therapeutics
Lentigo
Melanosis
Skin
Plant Extracts
Phytochemicals
Primary Care Physicians
Biological Products
MEDLINE
Industry
Databases

Keywords

  • botanical
  • hyperpigmentation
  • lentigo
  • melasma
  • natural
  • phytochemical
  • plant

ASJC Scopus subject areas

  • Dermatology

Cite this

The use of botanically derived agents for hyperpigmentation : A systematic review. / Fisk, Whitney A.; Agbai, Oma; Lev-Tov, Hadar A.; Sivamani, Raja K.

In: Journal of the American Academy of Dermatology, Vol. 70, No. 2, 02.2014, p. 352-365.

Research output: Contribution to journalArticle

@article{19e703e27c6047f1b0714e87cf9f1c06,
title = "The use of botanically derived agents for hyperpigmentation: A systematic review",
abstract = "Background Hyperpigmentation disorders are common among those seeking care from dermatologists and primary care physicians. The cosmeceutical and natural product industries are rapidly growing and many botanical agents are purported to improve hyperpigmentation disorders. Objective We sought to review clinical evidence for the use of botanical agents in the treatment of hyperpigmentation. Methods We searched MEDLINE and Embase databases and a total of 26 articles met inclusion criteria. Study methodology was analyzed and the reproducibility of the studies was graded. Results Several botanical agents appear promising as treatment options but few studies were methodologically rigorous. Several plant extract and phytochemicals effectively lighten signs of epidermal melasma and hyperpigmentation induced by ultraviolet radiation exposure. Results were mixed for treatment of solar lentigines or dermal hyperpigmentation. Limitations There were few rigorously designed studies; future research will be critical to further ascertain the discussed results. Conclusions The subtype of hyperpigmentation is important for treatment prognosis, with dermal hyperpigmentation less responsive to treatment. Botanical extracts may play an integrative role in the treatment of hyperpigmentation and further studies that integrate them with standard therapies are needed. Side effects, including worsened hyperpigmentation, need to be discussed when considering these therapies.",
keywords = "botanical, hyperpigmentation, lentigo, melasma, natural, phytochemical, plant",
author = "Fisk, {Whitney A.} and Oma Agbai and Lev-Tov, {Hadar A.} and Sivamani, {Raja K}",
year = "2014",
month = "2",
doi = "10.1016/j.jaad.2013.09.048",
language = "English (US)",
volume = "70",
pages = "352--365",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - The use of botanically derived agents for hyperpigmentation

T2 - A systematic review

AU - Fisk, Whitney A.

AU - Agbai, Oma

AU - Lev-Tov, Hadar A.

AU - Sivamani, Raja K

PY - 2014/2

Y1 - 2014/2

N2 - Background Hyperpigmentation disorders are common among those seeking care from dermatologists and primary care physicians. The cosmeceutical and natural product industries are rapidly growing and many botanical agents are purported to improve hyperpigmentation disorders. Objective We sought to review clinical evidence for the use of botanical agents in the treatment of hyperpigmentation. Methods We searched MEDLINE and Embase databases and a total of 26 articles met inclusion criteria. Study methodology was analyzed and the reproducibility of the studies was graded. Results Several botanical agents appear promising as treatment options but few studies were methodologically rigorous. Several plant extract and phytochemicals effectively lighten signs of epidermal melasma and hyperpigmentation induced by ultraviolet radiation exposure. Results were mixed for treatment of solar lentigines or dermal hyperpigmentation. Limitations There were few rigorously designed studies; future research will be critical to further ascertain the discussed results. Conclusions The subtype of hyperpigmentation is important for treatment prognosis, with dermal hyperpigmentation less responsive to treatment. Botanical extracts may play an integrative role in the treatment of hyperpigmentation and further studies that integrate them with standard therapies are needed. Side effects, including worsened hyperpigmentation, need to be discussed when considering these therapies.

AB - Background Hyperpigmentation disorders are common among those seeking care from dermatologists and primary care physicians. The cosmeceutical and natural product industries are rapidly growing and many botanical agents are purported to improve hyperpigmentation disorders. Objective We sought to review clinical evidence for the use of botanical agents in the treatment of hyperpigmentation. Methods We searched MEDLINE and Embase databases and a total of 26 articles met inclusion criteria. Study methodology was analyzed and the reproducibility of the studies was graded. Results Several botanical agents appear promising as treatment options but few studies were methodologically rigorous. Several plant extract and phytochemicals effectively lighten signs of epidermal melasma and hyperpigmentation induced by ultraviolet radiation exposure. Results were mixed for treatment of solar lentigines or dermal hyperpigmentation. Limitations There were few rigorously designed studies; future research will be critical to further ascertain the discussed results. Conclusions The subtype of hyperpigmentation is important for treatment prognosis, with dermal hyperpigmentation less responsive to treatment. Botanical extracts may play an integrative role in the treatment of hyperpigmentation and further studies that integrate them with standard therapies are needed. Side effects, including worsened hyperpigmentation, need to be discussed when considering these therapies.

KW - botanical

KW - hyperpigmentation

KW - lentigo

KW - melasma

KW - natural

KW - phytochemical

KW - plant

UR - http://www.scopus.com/inward/record.url?scp=84892675659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892675659&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2013.09.048

DO - 10.1016/j.jaad.2013.09.048

M3 - Article

VL - 70

SP - 352

EP - 365

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 2

ER -